谷歌浏览器插件
订阅小程序
在清言上使用
VIPCreated with Sketch.
研究兴趣

论文共 301 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
P-048 Barriers to the Implementation of Bispecific Antibodies for Patient with Relapsed and Refractory Myeloma in the UK: Results of a National Survey
May Low, Satarupa Choudhuri, Luke Steventon, Dunsi Bolarinwa, Chantelle Hughes, Anish Tailor,Bhuvan Kishore,Kamaraj Karunanithi,Ceri Bygrave, Adrian Shields, Andrea Preston, Peter Baker, Tiffany Chan, Pinkie Chambers,Rakesh Popat
Clinical Lymphoma Myeloma and Leukemia (2024): S68-S69
引用0浏览0引用
0
0
P-144 Oral Symptom Assessment Using Patient Reported Outcomes (PRO) for Relapsed Multiple Myeloma Patients Treated with Talquetamab
Rakesh Popat, Alexandra Greenwood,William Wilson, Catriona Mactier, Aviva Cerner,Sarah Worthington, Jennifer Russell, Chloe Jenkins, Daniel Hughes, Eileen Boyle, Annabel McMillan,Kwee Yong,Lydia Lee
Clinical Lymphoma Myeloma and Leukemia (2024): S123
引用0浏览0引用
0
0
Impact of Renal Impairment (RI) on Pharmacokinetics (PK) and Clinical Outcomes with Mezigdomide Plus Dexamethasone (DEX) in Relapsed/refractory Multiple Myeloma (RRMM)
Suzanne Trudel,Nizar J. Bahlis,Rakesh Popat,María‐Victoria Mateos,Annette Juul Vangsted, Karthik Ramasamy, Joaquín Martínez‐López,Hang Quach,Robert Z. Orlowski, Joseph W. Burnett, Allison Gaudy, Wen-Cong Chen,Jing Gong, Joseph T. Hadala, Cynthia Donahue,Phillip J. Koo, Yichao Zhu,Jessica Katz,Paul G. Richardson
Journal of clinical oncologyno. 16_suppl (2024): 7539-7539
引用0浏览0引用
0
0
OA-29 Mezigdomide (MEZI), Tazemetostat (TAZ), and Dexamethasone (DEX) in Patients (pts) with Relapsed/Refractory Multiple Myeloma (RRMM): Preliminary Results from the CA057-003 Trial
Luciano Costa,Rakesh Popat, David Siegel,Fredrik Schjesvold,Saad Usmani,Nizar J. Bahlis,Albert Oriol,Michael Chu, Syed Abbas Ali, Karthik Ramasamy,Monique Hartley-Brown, Joaquín Martínez-Lopez, Allison Gaudy, Antonina Kurtova, Wen Zhang,Rafael Sarmiento, August Dietrich,Jessica Katz,Michael Pourdehnad,Paul Richardson
Clinical Lymphoma Myeloma and Leukemia (2024): S19
引用0浏览0引用
0
0
P-066 Prophylactic Interventions for Oral Toxicities with the GPRC5D×CD3 Bispecific Antibody Talquetamab in Relapsed/Refractory Multiple Myeloma: an Open-Label, Phase 2, Randomized Study (TALISMAN)
Rakesh Popat, Alexa Laheij, Niels van de Donk, Richard Doty, Jim Omel,Brea Lipe, Leo Rasche, Ajai Chari, Kelly Kato, Ken Tian,Deeksha Vishwamitra, Jacqueline Speier, Mathilde Durand, Margaret Northup, Ibrahim Saber, William Prada,Kathleen Gray, Gloria Aguilar, Larysa Sanchez
Clinical Lymphoma Myeloma and Leukemia (2024): S79-S80
引用0浏览0引用
0
0
加载更多
作者统计

#Papers: 299

#Citation: 4146

H-Index: 32

G-Index: 60

Sociability: 8

Diversity: 0

Activity: 4

  • 合作者
  • 学生
  • 导师
暂无相似学者，你可以通过学者研究领域进行搜索筛选
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn